Sign inCreate account

Report workspace

Add to folder
NCT07299942RECRUITINGanonymous

Beta-glucan Supplementation During Calorie and Carbohydrate-restricted Diet: Impact on Body Weight and Body Fat Loss, Subjective Appetite, and Gastrointestinal Appetite Hormones of Healthy Women With Overweight.

Sponsor

Source record

University of Glasgow

Phase

Source record

Not Applicable

Modality

AI-normalized

combination therapy

Target

AI-normalized

Beta-glucan supplementation as an adjunct to calorie and carbohydrate restriction, focusing on appetite regulation and body composition.

Indication / condition

AI-normalized

Overweight and Obese Women

Intervention

Source record

Beta-glucan addition to a restricted calorie of meal replacements and carbohydrate diet., Cellulose (Placebo) addition to a restricted calorie of meal replacements and carbohydrate diet.

Source & freshness

Source record

NCT ID

NCT07299942

Original source

ClinicalTrials.gov

Source last updated

Dec 23, 2025

Ingested at

Jun 18, 2026

Internal sync

Jun 18, 2026

Model version

trialsignal-ai-v1

Normalized confidence

96%

Validation status

validated

Open original registry record
View original source fields

NCT ID

NCT07299942

Title

Beta-glucan Supplementation During Calorie and Carbohydrate-restricted Diet: Impact on Body Weight and Body Fat Loss, Subjective Appetite, and Gastrointestinal Appetite Hormones of Healthy Women With Overweight.

Sponsor

University of Glasgow

Status

RECRUITING

Phase

Not Applicable

Condition raw

Overweight and Obese Women

Condition normalized

Overweight and Obese Women

Modality raw

combination therapy

Modality normalized

combination therapy

Target raw

Beta-glucan supplementation as an adjunct to calorie and carbohydrate restriction, focusing on appetite regulation and body composition.

Target normalized

Beta-glucan supplementation as an adjunct to calorie and carbohydrate restriction, focusing on appetite regulation and body composition.

Interventions

Beta-glucan addition to a restricted calorie of meal replacements and carbohydrate diet., Cellulose (Placebo) addition to a restricted calorie of meal replacements and carbohydrate diet.

Public preview

Source record

The clinical trial sponsored by the University of Glasgow aims to evaluate the efficacy of beta-glucan supplementation in promoting weight loss and appetite regulation among overweight and obese women. If successful, this study could position beta-glucan as a valuable dietary supplement in the weight management market, which is projected to grow significantly due to rising obesity rates globally. The competitive landscape includes various dietary supplements and weight loss products, necessitating a thorough market analysis to identify potential partnerships or acquisition targets. Diligence should focus on regulatory pathways for dietary supplements and the potential for claims based on trial outcomes.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Full protocol, outcomes, eligibility, contacts and results sections
Patent/IP landscape with verified records when available
Board-ready PDF export with source provenance
Save to folders and synthesize multiple assets in premium workspace
Create account
Sign in

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

Beta-glucan Supplementation During Calorie and Carbohydrate-restricted Diet: Impact on Body Weight and Body Fat Loss, Subjective Appetite, and Gastrointestinal Appetite Hormones of Healthy Women With Overweight.

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jun 18, 2026

NCT ID

NCT07299942

Status

RECRUITING

Phase

Not Applicable

Sponsor

University of Glasgow

Executive brief

Investment-Ready Snapshot

The clinical trial sponsored by the University of Glasgow aims to evaluate the efficacy of beta-glucan supplementation in promoting weight loss and appetite regulation among overweight and obese women. If successful, this study could position beta-glucan as a valuable dietary supplement in the weight management market, which is projected to grow significantly due to rising obesity rates globally. The competitive landscape includes various dietary supplements and weight loss products, necessitating a thorough market analysis to identify potential partnerships or acquisition targets. Diligence should focus on regulatory pathways for dietary supplements and the potential for claims based on trial outcomes.

Source & freshness

Provenance

SourceClinicalTrials.gov
Source updatedDec 23, 2025
Internal syncJun 18, 2026
Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT07299942

Indication

Overweight and Obese Women

Modality

combination therapy

Target

Beta-glucan supplementation as an adjunct to calorie and carbohydrate restriction, focusing on appetite regulation and body composition.

Intervention

Beta-glucan addition to a restricted calorie of meal replacements and carbohydrate diet., Cellulose (Placebo) addition to a restricted calorie of meal replacements and carbohydrate diet.

Source record

Protocol Description

Detailed source ingestion pending.

Source record

Outcome Measures

Detailed source ingestion pending.

Source record

Eligibility

Detailed source ingestion pending.

AI analysis

Known Results And Readout Context

Detailed source ingestion pending.

IP intelligence

Patent And IP Landscape

Detailed source ingestion pending.

Source record

Contacts

Detailed source ingestion pending.